文献速递区域麻醉与超声术前评估与围术期医学

超声引导与体表标志引导椎管内穿刺的有效性与安全性:系统评价、网状Meta分析与试验序贯分析

Efficacy and safety of ultrasound-guided versus landmark-guided neuraxial puncture: a systematic review, network meta-analysis and trial sequential analysis of randomized clinical trials.
PubMed 文献 · Reg Anesth Pain Med · 2025-09-04

该系统评价与网状Meta分析纳入71项随机试验共7153例接受椎管内穿刺的成人患者,比较实时超声、操作前超声与体表标志触诊引导。结果显示实时超声(OR 0.30;95%CrI 0.15–0.58;低确定性)与操作前超声(OR 0.33;95%CrI 0.24–0.44;中等确定性)均显著降低首次穿刺失败风险,操作前超声还显著降低完全穿刺失败风险(OR 0.29;95%CrI 0.11–0.61),但实时超声与操作前超声孰优尚未明确。

要点

  • 实时超声与操作前超声均显著降低首次椎管内穿刺失败风险。
  • 操作前超声显著降低完全穿刺失败风险(OR 0.29;95%CrI 0.11–0.61)。
  • 实时超声与操作前超声孰优未确立,证据确定性低至中等。

核心结论

  • 超声引导椎管内穿刺可提高有效性、减少穿刺尝试与针调整、降低部分并发症风险并提高患者满意度,证据确定性为低至中等。
  • 实时超声排名虽高,但未确立其优于操作前超声。

研究设计与样本

  • 系统评价、网状Meta分析与试验序贯分析,检索六个数据库的随机对照试验。
  • 纳入71项研究共7153例接受椎管内穿刺的成人患者,比较实时超声、操作前超声与体表标志触诊。
  • 主要结局为首次椎管内穿刺失败,采用GRADE方法评估证据确定性。

主要发现

  • 实时超声降低首次穿刺失败风险(OR 0.30;95%CrI 0.15–0.58;低确定性)。
  • 操作前超声降低首次穿刺失败风险(OR 0.33;95%CrI 0.24–0.44;中等确定性)。
  • 实时超声在降低完全穿刺失败风险方面排名领先,但与体表标志触诊比较差异无统计学意义。
  • 操作前超声显著降低完全穿刺失败风险(OR 0.29;95%CrI 0.11–0.61)。
  • 超声引导方法减少部分并发症并提高患者满意度,其他结局无显著差异;试验序贯分析确认主要结局信息充分。

临床怎么用

  • 麻醉科医生可考虑采用超声引导椎管内穿刺以降低首次穿刺失败风险。
  • 操作前超声可作为减少完全穿刺失败的选择。
  • 实时超声与操作前超声的选择需结合临床场景,不强求实时引导。

局限性

  • 证据确定性为低至中等。
  • 实时超声与操作前超声的优越性未明确建立。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data suggest that preprocedural ultrasound may improve the efficacy of central neuraxial puncture. However, it remains uncertain whether these findings can be extended to various clinical scenarios, including diverse patient populations and the application of real-time ultrasound guidance. Additionally, it is unclear whether ultrasound-guided techniques improve safety and patient-centered outcomes. METHODS: We searched six databases for randomized trials of adult patients undergoing neuraxial puncture, comparing real-time ultrasound, preprocedural ultrasound, and landmark palpation for efficacy, safety and patient-centered outcomes. Our primary outcome was a failed first-attempt neuraxial puncture. After two-person screening and data extraction, meta-analyses were conducted and the Grading of Recommendations Assessment, Development and Evaluation approach was applied to assess the certainty of evidence. RESULTS: Analysis of 71 studies involving 7153 patients, both real-time ultrasound (OR 0.30; 95% credible interval (CrI) 0.15 to 0.58; low certainty) and preprocedural ultrasound (OR 0.33; 95% CrI 0.24 to 0.44; moderate certainty) showed a significant reduction in the risk of a failed first neuraxial puncture. Real-time ultrasound had the best performance for preventing first-attempt failures (low certainty evidence). Although real-time ultrasound was also the leading method for reducing the risk of complete neuraxial puncture failure, the results did not show a statistically significant difference when compared with landmark palpation. Preprocedural ultrasound, however, significantly reduced the odds of complete puncture failure (OR 0.29; 95% CrI 0.11 to 0.61). These ultrasound-guided approaches also contributed to a reduction in certain complications and increased patient satisfaction without any other significant differences in additional outcomes. Trial sequential analysis confirmed that sufficient information was achieved for our primary outcome. CONCLUSIONS: Ultrasound-guided neuraxial puncture improves efficacy, reduces puncture attempts and needle redirections, reduces complication risks, and increases patient satisfaction, with low to moderate certainty of evidence. Despite real-time ultrasound's high ranking, a clear superiority over preprocedural ultrasound is not established. These results could prompt anesthesiologists and other clinicians to reassess their neuraxial puncture techniques.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. de Carvalho CC, Porto Genuino W, Vieira Morais MC, et al. Efficacy and safety of ultrasound-guided versus landmark-guided neuraxial puncture: a systematic review, network meta-analysis and trial sequential analysis of randomized clinical trials. Reg Anesth Pain Med. 2025. PMID: 38876801. doi:10.1136/rapm-2024-105547

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。